Browsing: Toxicology

Toxicology

It's Getting HOT in Here! A Review of Serotonin Syndrome

11/30/2017 Stephen Hallisey, MD , Joshua Glick, MD , Clinton J. Orloski, MD

It's Getting HOT in Here! A Review of Serotonin Syndrome You are called to evaluate a 74-year-old woman who was found by her daughter, confused and unable to get out of bed. The patient's only medica

Health Policy Journal Club , Medications , Health Policy , Regulatory

Health Policy Journal Club: The Front Lines of the Opioid Epidemic

11/6/2017 Brandon Roe, DO

Health Policy Journal Club: The Front Lines of the Opioid Epidemic Mandating use of prescription drug monitoring programs cuts opioids by up to 10% Opioid prescriptions in the United States have been

Medications , Toxicology

Atrial Fibrillation after Naloxone Administration: A Rare Complication of Opioid Reversal

10/5/2017 Megan Gillespie, DO , Maricel Dela Cruz, DO, MPH , Jay Slutsky, DO

Atrial Fibrillation after Naloxone Administration: A Rare Complication of Opioid Reversal Background Naloxone is a widely used antidote critical in reversing the lethal effect of respiratory depressi

Toxicology , Toxins

Chemical Warfare Agents

10/3/2017 Navneet Cheema, MD , Natalie Neumann, MD

Chemical Warfare Agents Today, chemical warfare agents (CWAs) may pose a greater hazard to civilians than soldiers. The threat of chemical warfare is hardly novel. Traditionally used by armies to bre

Recreational Drugs , Toxicology

Tripping off Trumpets: Diagnosis and Management of Jimson Weed Toxicity

8/14/2017 Henrik Galust, MD

Tripping off Trumpets: Diagnosis and Management of Jimson Weed Toxicity A 16-year-old male is brought to the emergency department for confusion and hallucinations for the past hour. Two hours prior t

Toxicology , Medications

Take-Home Naloxone: Preventing Death in an Era of Abuse

6/5/2017 Thomas del Ninno, MD , R. Gentry Wilkerson, MD, FACEPP , Danya Khoujah, MD

Take-Home Naloxone: Preventing Death in an Era of Abuse The United States is in the midst of an opioid epidemic, resulting in a significant increase in overdose deaths.1 From 2000 to 2014, there was

Toxicology

Don't Kid Around: SGLT-2 Inhibitors and the Risk for Euglycemic DKA

6/5/2017 Sajid Khan, MD , Maryam Arshad, MD

Don't Kid Around: SGLT-2 Inhibitors and the Risk for Euglycemic DKA A 62-year-old female presents with cough and generalized weakness for one day. She has no other symptoms and physical exam is unrem

Legislation , Recreational Drugs , Health Policy

Weeding through the Effects of Marijuana Legalization

4/1/2017 Patrick Wallace, DO

Weeding through the Effects of Marijuana Legalization Legalization of marijuana has become a heated topic in the United States as 8 states and Washington, D.C., have legalized it for recreational use

Toxicology , Clinical

Mad as a Hatter: Physostigmine for Delirium Control in Anticholinergic Toxicity

4/1/2017 Sean Boley, MD , Natalia Rumas, MD

Mad as a Hatter: Physostigmine for Delirium Control in Anticholinergic Toxicity A 34-year-old female with a history of bipolar disorder, depression, and multiple previous suicide attempts is brought